Biocryst Pharmaceuticals: Pay

Biocryst Pharmaceuticals paid its 4 named executives $26.3M in total in FY2025 (Dec). CEO Charles K. Gayer was paid $9.6M of that.

Pay$100 in the stock at the end of FY21 → $56
CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

Charles K. GayerPresident and Chief Executive Officer; Former Chief Commercial Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
4 years
Jon P. StonehouseFormer President and Chief Executive Officer
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
4 years
Babar GhiasChief Financial Officer
FY2025 (Dec)
1 year
Alane P. BarnesChief Legal Officer and Corporate Secretary
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
4 years
Helen M. Thackray, M.D.Former Chief R&D Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
5 years
Anthony J. DoyleFormer Chief Financial Officer and Treasurer
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
4 years

CEO pay against the pay peers

In FY2025 (Dec), the median CEO pay of the 7 peers with pay on file was $10.4M. CEO pay of Biocryst Pharmaceuticals for that year is not on file.

  1. 1PTC Therapeutics
  2. 2INSMED
  3. 3Ultragenyx Pharmaceutical
  4. 4Mirum Pharmaceuticals
  5. 5Adma Biologics
  6. 6Travere Therapeutics
  7. 7Harmony Biosciences Holdings
  8. 8Biocryst PharmaceuticalsNot disclosed
  9. 9Acadia PharmaceuticalsNot disclosed
  10. 10Amicus TherapeuticsNot disclosed
  11. 11Apellis PharmaceuticalsNot disclosed
  12. 12ArdelyxNot disclosed
  13. 13Arrowhead PharmaceuticalsNot disclosed
  14. 14Catalyst PharmaceuticalsNot disclosed
  15. 15Corcept TherapeuticsNot disclosed
  16. 16Dynavax TechnologiesNot disclosed
  17. 17Pacira BioSciencesNot disclosed
  18. 18Rhythm PharmaceuticalsNot disclosed
  19. 19SIGA TechnologiesNot disclosed

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.